Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)

March 2000

Glaxo is now starting to promote Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS).

This will be big.

Approx 30 million Americans have irritable bowel syndrome...leading to chronic abdominal pain, cramps, diarrhea and/or constipation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether hormone replacement therapy increases the risk of breast cancer
Gastroenterology Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)
Pediatrics Augmentin is more effective than Zithromax for otitis media
Pediatrics The first oral solution that contains ONLY trimethoprim
Immunizations new 2-dose regimen for giving Recombivax HB (hepatitis B vaccine) to ADOLESCENTS
Immunizations more widespread use of varicella vaccine (Varivax)
Cardiology whether vitamin E reduces the risk of heart disease
Women's Health Ortho-Prefest, a new combo HRT regimen for postmenopausal women
Women's Health metformin for Polycystic Ovary Syndrome (PCOS)
Ophthalmology three new eye drops for itching due to allergic conjunctivitis
Infectious Diseases Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia
Infectious Diseases Sporanox (itraconazole) now comes in IV form
which calcium supplement to recommend for a particular patient
Antiepileptics two new anti-epileptics
drug interactions with St. John's wort